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Services provided by a drug information center were helpful with improving patient 
care, reducing inappropriate pharmaceutical expenditures, and increasing the 
healthcare teams overall outlook on the profession of pharmacy.
Currently, no drug information centers exist 
in the Bahamas or Caribbean Islands.  There 
is a significant strain placed on the Public 
Hospitals Authority pharmacy budget in the 
Bahamas. The ability to purchase multiple 
medications in the same therapeutic class 
without beneficial cost analysis provided by 
drug information centers, specifically drug 
utilization reviews to the Pharmacy and 
Therapeutics Committee, has depleted the 
hospital’s budget. This project is designed to 
show how cost-effective it is to have a drug 
information center in the Bahamas and 
surrounding Caribbean Islands.
Drug utilization reviews were prepared on four 
therapeutic classes by the University of New 
England’s College of Pharmacy Dalliere Drug 
Information Center. These were conducted to 
demonstrate an improvement of drug therapy, 
increase the patients’ quality of care, enhance 
therapeutic outcomes, reduce inappropriate 
pharmaceutical expenditures, and finally, 
reduce overall health care costs. Based on the 
information provided from the drug utilization 
reviews to the Pharmacy and Therapeutics 
committee, the proper adjustments were made 
to the formulary. The cost savings were 
documented over a period of three months and 
presented to hospital administrators.
 Total saving per month for the four therapeutic   
classes were $13,176, $1,031, $12,480,and $1,914 
Average total savings of $342,618 for fiscal year
 Hospital administrators voted for investment in 
creating a drug information center
 Increased administrators ability to provide needed 
pharmaceutical care
Alleviated cost expenditures 
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